Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Codexis (CDXS) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Codexis (CDXS) over the last 16 years, with Q3 2025 value amounting to $905000.0.

  • Codexis' Change in Account Payables fell 331.2% to $905000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 26343.78%. This contributed to the annual value of -$2.6 million for FY2024, which is 21224.31% down from last year.
  • Per Codexis' latest filing, its Change in Account Payables stood at $905000.0 for Q3 2025, which was down 331.2% from -$3.5 million recorded in Q2 2025.
  • Over the past 5 years, Codexis' Change in Account Payables peaked at $2.4 million during Q4 2023, and registered a low of -$3.5 million during Q2 2025.
  • Its 5-year average for Change in Account Payables is -$15684.2, with a median of $71000.0 in 2022.
  • As far as peak fluctuations go, Codexis' Change in Account Payables surged by 33669.06% in 2022, and later tumbled by 136118.14% in 2025.
  • Quarter analysis of 5 years shows Codexis' Change in Account Payables stood at -$307000.0 in 2021, then skyrocketed by 281.76% to $558000.0 in 2022, then surged by 328.67% to $2.4 million in 2023, then tumbled by 151.34% to -$1.2 million in 2024, then skyrocketed by 173.7% to $905000.0 in 2025.
  • Its Change in Account Payables was $905000.0 in Q3 2025, compared to -$3.5 million in Q2 2025 and $2.1 million in Q1 2025.